505 related articles for article (PubMed ID: 31496619)
1. Systemic inflammation in colorectal cancer: Underlying factors, effects, and prognostic significance.
Tuomisto AE; Mäkinen MJ; Väyrynen JP
World J Gastroenterol; 2019 Aug; 25(31):4383-4404. PubMed ID: 31496619
[TBL] [Abstract][Full Text] [Related]
2. The Role of Tumor Microenvironment Cells in Colorectal Cancer (CRC) Cachexia.
Kasprzak A
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33557173
[TBL] [Abstract][Full Text] [Related]
3. Systemic inflammation, nutritional status and survival in patients with cancer.
McMillan DC
Curr Opin Clin Nutr Metab Care; 2009 May; 12(3):223-6. PubMed ID: 19318937
[TBL] [Abstract][Full Text] [Related]
4. Systemic inflammation, cachexia and prognosis in patients with cancer.
Deans C; Wigmore SJ
Curr Opin Clin Nutr Metab Care; 2005 May; 8(3):265-9. PubMed ID: 15809528
[TBL] [Abstract][Full Text] [Related]
5. The correlation between a chronic inflammatory marker Tartrate-resistant acid phosphatase 5a with cancer cachexia.
Wu YY; Chao TY; Liu HY; Huang TC; Chen JH; Dai MS; Janckila A; Lai SW; Chang PY
J BUON; 2015; 20(1):325-31. PubMed ID: 25778334
[TBL] [Abstract][Full Text] [Related]
6. Inflammation based regulation of cancer cachexia.
Onesti JK; Guttridge DC
Biomed Res Int; 2014; 2014():168407. PubMed ID: 24877061
[TBL] [Abstract][Full Text] [Related]
7. Alterations in serum amino-acid profile in the progression of colorectal cancer: associations with systemic inflammation, tumour stage and patient survival.
Sirniö P; Väyrynen JP; Klintrup K; Mäkelä J; Karhu T; Herzig KH; Minkkinen I; Mäkinen MJ; Karttunen TJ; Tuomisto A
Br J Cancer; 2019 Jan; 120(2):238-246. PubMed ID: 30563990
[TBL] [Abstract][Full Text] [Related]
8. How can we modulate cytokine production and action?
Cynober L
Nestle Nutr Workshop Ser Clin Perform Programme; 2005; 10():219-232. PubMed ID: 15818032
[No Abstract] [Full Text] [Related]
9. Cachexia, survival and the acute phase response.
Stephens NA; Skipworth RJ; Fearon KC
Curr Opin Support Palliat Care; 2008 Dec; 2(4):267-74. PubMed ID: 19060563
[TBL] [Abstract][Full Text] [Related]
10. Significance of inflammatory cytokines in the progression of colorectal cancer.
Chung YC; Chang YF
Hepatogastroenterology; 2003; 50(54):1910-3. PubMed ID: 14696431
[TBL] [Abstract][Full Text] [Related]
11. IL-6-like cytokines and cancer cachexia: consequences of chronic inflammation.
Barton BE
Immunol Res; 2001; 23(1):41-58. PubMed ID: 11417859
[TBL] [Abstract][Full Text] [Related]
12. Proinflammatory cytokines in CRP baseline regulation.
Eklund CM
Adv Clin Chem; 2009; 48():111-36. PubMed ID: 19803417
[TBL] [Abstract][Full Text] [Related]
13. Cancer cachexia: malignant inflammation, tumorkines, and metabolic mayhem.
Tsoli M; Robertson G
Trends Endocrinol Metab; 2013 Apr; 24(4):174-83. PubMed ID: 23201432
[TBL] [Abstract][Full Text] [Related]
14. Significance of Markers of Systemic Inflammation for Predicting Survival and Chemotherapeutic Outcomes and Monitoring Tumor Progression in Patients with Unresectable Metastatic Colorectal Cancer.
Shibutani M; Maeda K; Nagahara H; Ohtani H; Sakurai K; Yamazoe A; Kimura K; Toyokawa T; Amano R; Kubo N; Tanaka H; Muguruma K; Ohira M; Hirakawa K
Anticancer Res; 2015 Sep; 35(9):5037-46. PubMed ID: 26254405
[TBL] [Abstract][Full Text] [Related]
15. Cancer- and cardiac-induced cachexia: same fate through different inflammatory mediators?
Nogueira-Ferreira R; Sousa-Nunes F; Leite-Moreira A; Moreira-Costa L; Vitorino R; Lara Santos L; Moreira-Gonçalves D; Ferreira R
Inflamm Res; 2022 Aug; 71(7-8):771-783. PubMed ID: 35680678
[TBL] [Abstract][Full Text] [Related]
16. [The relation between depression and inflammation].
Fisker L; Köhler-Forsberg O; Hageman I
Ugeskr Laeger; 2018 May; 180(20):. PubMed ID: 29761778
[TBL] [Abstract][Full Text] [Related]
17. Diabetes increases mortality in patients with pancreatic and colorectal cancer by promoting cachexia and its associated inflammatory status.
Chovsepian A; Prokopchuk O; Petrova G; Gjini T; Kuzi H; Heisz S; Janssen KP; Martignoni ME; Friess H; Hauner H; Rohm M
Mol Metab; 2023 Jul; 73():101729. PubMed ID: 37094629
[TBL] [Abstract][Full Text] [Related]
18. Alterations in inflammatory biomarkers and energy intake in cancer cachexia: a prospective study in patients with inoperable pancreatic cancer.
Bye A; Wesseltoft-Rao N; Iversen PO; Skjegstad G; Holven KB; Ulven S; Hjermstad MJ
Med Oncol; 2016 Jun; 33(6):54. PubMed ID: 27119533
[TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory therapies in cancer cachexia.
Argilés JM; Busquets S; López-Soriano FJ
Eur J Pharmacol; 2011 Sep; 668 Suppl 1():S81-6. PubMed ID: 21835173
[TBL] [Abstract][Full Text] [Related]
20. Inflammation in sporadic colorectal cancer.
Moossavi S; Bishehsari F
Arch Iran Med; 2012 Mar; 15(3):166-70. PubMed ID: 22369306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
